FORGOTTEN HISTORY: Evogene ltd | History Defined

Evogene Reports Wider Loss In 2021, $54M In Consolidated Cash

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) announced its financial results for the fourth quarter and full year of 2021, ended December 31, 2021.

Benzinga · Mar 10, 2022

Medical-Grade Cannabis Developer Canonic Appoints Ex-SEO At Israeli Ministry Of Health To Its Board

Medical-grade cannabis developer Canonic Ltd., and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN), announced that professor Itamar Grotto will be joining its board of directors.

Benzinga · Feb 16, 2022

Evogene Co, 'When Biology Meets Disruptive Technologies,' Confirms Earnings Results Release Date

Computational biology company Evogene Ltd. (NASDAQ: EVGN)  will release its financial results for the full year and fourth quarter of 2021 on March 10, 2022.

Benzinga · Feb 15, 2022